A newglyco-biomarker for measuring infectious hepatitis B virus targeting surface antigen glycan isomer (HBsAgGi)

被引：0
|
作者：
Angata, Kiyohiko [1 ]
Sogabe, Maki [1 ]
Narimatsu, Hisashi [1 ]
Murata, Ayato [2 ]
Genda, Takuya [2 ]
机构：
[1] RCMG Inc, Tsukuba, Japan
[2] Juntendo Univ, Dept Gastroenterol & Hepatol, Shizuoka Hosp, Tokyo, Japan
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-257
引用
收藏
页码：S1041 / S1041
页数：1
相关论文
共 50 条
  • [1] HEPATITIS B VIRUS SURFACE ANTIGEN GLYCAN ISOMER ( HBSAGGI) AS A NEW GLYCO- BIOMARKER TO DETECT INFECTIOUS HBV VIRIONS
    Angata, Kiyohiko
    Sogabe, Maki
    Narimatsu, Hisashi
    Ayato, Murata
    Genda, Takuya
    HEPATOLOGY, 2023, 78 : S429 - S430
  • [2] Hepatitis B surface antigen glycan isomer as a new potential biomarker in patients with hepatitis B virus infection
    Okumura, Taiki
    Umemura, Takeji
    HEPATOLOGY RESEARCH, 2024, 54 (10) : 874 - 876
  • [3] Hepatitis B surface antigen (HBsAg) glycan isomer is predictive of HBsAg seroclearance in patients with chronic hepatitis B
    Ikeda, Yuji
    Murata, Ayato
    Nago, Hiroki
    Yamaguchi, Masahiro
    Om, Rihwa
    Terai, Yuichro
    Kita, Yuji
    Sato, Sho
    Sato, Shunsuke
    Shimada, Yuji
    Genda, Takuya
    HEPATOLOGY RESEARCH, 2024, 54 (10) : 888 - 898
  • [4] INFECTIOUS VACCINIA VIRUS RECOMBINANTS THAT EXPRESS HEPATITIS-B VIRUS SURFACE-ANTIGEN
    SMITH, GL
    MACKETT, M
    MOSS, B
    NATURE, 1983, 302 (5908) : 490 - 495
  • [5] Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy
    Kozuka, Ritsuzo
    Enomoto, Masaru
    Yukawa-Muto, Yoshimi
    Odagiri, Naoshi
    Kotani, Kohei
    Motoyama, Hiroyuki
    Kawamura, Etsushi
    Hagihara, Atsushi
    Fujii, Hideki
    Uchida-Kobayashi, Sawako
    Kawada, Norifumi
    HEPATOLOGY RESEARCH, 2024, 54 (07) : 615 - 626
  • [6] Regarding the "Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy"
    Huang, Wei
    Zheng, Yan
    HEPATOLOGY RESEARCH, 2024, 54 (12) : 1234 - 1234
  • [7] Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B
    Fung, James
    Lai, Ching-Lung
    Yuen, Man-Fung
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (06) : 717 - 726
  • [8] Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues
    Chen, Lizhang
    Liu, Fuqiang
    Fan, Xuegong
    Gao, Jianming
    Chen, Nengzhi
    Wong, Tom
    Wu, Jun
    Wen, Shi Wu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (01) : 20 - 23
  • [9] A small molecule targeting hepatitis B surface antigen inhibits clinically relevant drug-resistant hepatitis B virus
    Kiruthika, S.
    Bhat, Ruchika
    Jayaram, B.
    Vivekanandan, Perumal
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (08) : 2120 - 2124
  • [10] Detection of hepatitis B virus surface antigen in hepatitis B vaccine recipients
    Chawla, YK
    Sharma, SK
    Saini, N
    Arora, L
    Masih, B
    Duseja, A
    Dhiman, RK
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S104 - S105
12345